DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Form Health pairs you with a board-certified obesity medicine physician and accepts most major insurance.
Form Health stands out among telehealth weight-loss services because it is run by physicians certified by the American Board of Obesity Medicine (ABOM), not general clinicians, and pairs every patient with a registered dietitian for ongoing behavioral support. It is genuinely useful if you have an obesity diagnosis and want medically supervised care that can be billed to most major insurers. It is overkill (and pricier) if you only want a fast, cheap GLP-1 prescription with minimal follow-up.
Form Health is a telehealth obesity clinic, not a drug itself. After an online intake, you are matched with a care team led by an ABOM-certified obesity-medicine physician (or advanced practice provider) plus a registered dietitian. They review your history and, when medically appropriate, prescribe FDA-approved anti-obesity medications such as Wegovy (semaglutide), Zepbound (tirzepatide), Saxenda (liraglutide), or Contrave. Most of these are GLP-1-based drugs that mimic gut hormones to slow stomach emptying, reduce appetite, and curb cravings (tirzepatide also acts on the GIP receptor). Care is delivered through video visits, unlimited messaging, and an app for weight and food tracking, combining medication with nutrition and behavior change.
Active ingredient: Brand-name GLP-1 (Wegovy, Zepbound, etc.)
Form Health reports an average of 16% body-weight loss at 18 months across its patients (with and without medication), but this is the company's own internal program data, not an independently published, peer-reviewed clinical trial, so treat it as a marketing claim rather than proof. The medications Form prescribes do have strong trial evidence. In the STEP-1 trial (NEJM, 2021), adults on weekly semaglutide 2.4 mg (Wegovy) lost an average of about 14.9% of body weight at 68 weeks versus 2.4% on placebo. In SURMOUNT-1 (NEJM, 2022), tirzepatide (Zepbound) produced average losses of roughly 15% to 21% over 72 weeks depending on dose (about 15.0% at 5 mg up to 20.9% at 15 mg in the primary analysis, and higher, up to about 22.5%, among adherent participants). Real-world telehealth outcomes are often somewhat lower than trial figures because of drug discontinuation and adherence.
Side effects come from the prescribed medication, not the service itself. The most common with GLP-1 drugs (Wegovy, Zepbound, Saxenda) are gastrointestinal: nausea, diarrhea, vomiting, constipation, and abdominal discomfort, usually mild-to-moderate and worst during dose escalation. Contrave can cause nausea, headache, constipation, insomnia, and raised blood pressure. Serious but uncommon risks include acute pancreatitis, gallbladder disease, and kidney injury from dehydration. GLP-1 drugs carry an FDA boxed warning for thyroid C-cell tumors seen in rodents and are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. Seek prompt medical care for severe, persistent abdominal pain.
Starts at $99/mo from Form Health.
As of 2026, Form Health's self-pay membership is about $299/month, which is HSA/FSA-eligible and covers physician and dietitian visits, messaging, and the app, but not medications or lab work. GLP-1 drugs can cost roughly $500 to $1,300 or more per month at cash price (manufacturer savings programs and lower-cost direct-pay vials for Wegovy and Zepbound can reduce this). Alternatively, Form can bill visits, labs, and medications through most major private insurance plans, in which case you pay only copays and deductibles, which can dramatically lower total cost. Medicare is more limited: by federal law it does not cover a drug prescribed solely for weight loss, so a GLP-1 is generally covered only when prescribed for a separate approved indication such as type 2 diabetes or cardiovascular risk reduction. Coverage varies widely by plan, so verify your specific benefits in writing before starting.
If you want obesity treated as a chronic medical condition with specialist oversight, dietitian coaching, and the ability to bill most private insurers, Form Health is one of the more credible options. The main drawbacks are a $299/month fee that does not include drugs or labs, the requirement to already have a primary care provider, and repeated patient complaints about insurance-verification surprises and scheduling waits. Medicare coverage is limited, because federal law excludes drugs used solely for weight loss. Confirm your coverage in writing before you start, and treat this as general information, not medical advice.
Yes. Form Health is an established US telehealth obesity clinic founded in 2019, staffed by physicians certified by the American Board of Obesity Medicine and by registered dietitians, and backed by venture funding. It holds an A- Better Business Bureau rating and a roughly 4.4-star Trustpilot rating across hundreds of reviews, though some complaints cite billing and scheduling issues.
As of 2026, Form Health's self-pay membership is about $299 per month, covering physician and dietitian visits, messaging, and the app. Medications and lab work cost extra. If you use insurance, you instead pay applicable copays and deductibles, which can be much lower; the self-pay fee is HSA/FSA eligible.
Form Health bills visits, labs, and medications through most major private insurance plans, and you pay only your copay or deductible. Medicare is more limited: federal law bars Medicare from covering a drug used solely for weight loss, so a GLP-1 is generally covered only when prescribed for a separate approved indication such as type 2 diabetes or cardiovascular risk reduction. Verify your specific benefits in writing before you start.
Form Health prescribes FDA-approved anti-obesity medications, including the GLP-1 injectables Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide), plus the oral pill Contrave. The physician selects the medication based on your medical history when treatment is appropriate.
Yes. Form Health requires that you have a primary care provider and have seen them within the past 12 months. Form coordinates with your PCP rather than replacing them, so you must establish primary care before or alongside starting the program.
US adults 18 and older with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol. People who are pregnant or breastfeeding, those seeking eating-disorder treatment, or anyone with contraindications to the medications are not candidates.
Form Health reports an average of about 16% body-weight loss at 18 months across its patients, though this is internal company data, not a peer-reviewed trial. The GLP-1 drugs it prescribes produced roughly 15% (semaglutide, STEP-1) to about 21% (tirzepatide at the highest dose, SURMOUNT-1) average loss in published clinical trials. Individual results vary, and real-world losses are often lower.
Yes. Form Health states you can cancel your membership at any time, and the care team helps create a transition plan. Confirm any billing-cycle details directly with their care advisors so you are not charged for an additional month.